FDA Drug Recalls

Recalls / Class II

Class IID-0608-2022

Product

Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: RITE AID, 30 HUNTER LANE, CAMP HILL, PA 17011. NDC 11822-6378-1

Brand name
Nasal
Generic name
Oxymetazoline Hydrochloride
Active ingredient
Oxymetazoline Hydrochloride
Route
Nasal
NDC
11822-6378
FDA application
M012
Affected lot / code info
Batch: 11BK0827, Exp 12/31/2022

Why it was recalled

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Recalling firm

Firm
Perrigo Company PLC
Manufacturer
Rite Aid Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, Allegan, Michigan 49010-9070

Distribution

Quantity
9,888 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-10-26
FDA classified
2022-02-23
Posted by FDA
2022-03-02
Terminated
2023-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0608-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.